Skip to main content
hello world

Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.

Health and Wellness Industry Embraces Surge in Demand for Weight Loss Drugs

Newswire.ca - Thu Oct 24, 8:17AM CDT

USA News Group News Commentary
Issued on behalf of PlantX Life Inc.

VANCOUVER, BC, Oct. 24, 2024/CNW/ -- USA News GroupNews Commentary With more than 100 million Americans struggling with obesity, and obesity rates increasing on every continent, it's no wonder why analysts at SNS Insider are projecting the Weight Loss Drugs Market to grow at a whopping 43.73% CAGR through 2032. It's one of the fastest growing markets in pharmaceuticals, with nearly one in four employers saying they're either somewhat or very likely to begin covering the cost of anti-obesity medications within the next year. Health and wellness companies are responding in kind, with recent market developments coming from: PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF), Novo Nordisk A/S (NYSE: NVO), Eli Lilly and Company (NYSE: LLY), Viking Therapeutics, Inc. (NASDAQ: VKTX), and Roche Holding AG (OTCQX: RHHBY).

Read more at newswire.ca